The Goldman Sachs Group Initiates Coverage on Omada Health (NASDAQ:OMDA)

The Goldman Sachs Group started coverage on shares of Omada Health (NASDAQ:OMDA) in a research report report published on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $29.00 target price on the stock.

OMDA has been the subject of a number of other reports. Canaccord Genuity Group assumed coverage on shares of Omada Health in a report on Tuesday. They set a “buy” rating and a $27.00 target price for the company. Wall Street Zen upgraded Omada Health to a “hold” rating in a report on Monday, June 16th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and an average price target of $23.57.

Omada Health Trading Up 2.9%

Shares of OMDA opened at $18.63 on Tuesday. Omada Health has a twelve month low of $14.14 and a twelve month high of $28.40.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.